Cannabis (seeing through the smoke): The New Science of Cannabis and Your Health
Regular price
€16.10
14 days return policy
Shipping & Delivery
A01=Professor David Nutt
Addiction and drugs
Age Group_Uncategorized
Age Group_Uncategorized
Alcohol
Author_Professor David Nutt
automatic-update
Books for men
Books on drugs
Books on weed
Category1=Non-Fiction
Category=JMT
Category=MMGW
Category=PDZ
COP=United Kingdom
Delivery_Delivery within 10-20 working days
Drug misuse.
Drug policy
Drugs
eq_bestseller
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_science
eq_society-politics
Health
Language_English
PA=Available
Price_€10 to €20
PS=Active
Psychopharmacology
Science
Science books
Social science
softlaunch
Why do people take drugs
Product details
- ISBN 9781529360523
- Weight: 202g
- Dimensions: 128 x 196mm
- Publication Date: 15 Feb 2024
- Publisher: Hodder & Stoughton
- Publication City/Country: United Kingdom
- Language: English
Secure
checkout
Fast Shipping
Easy returns
THE DEFINITIVE GUIDE TO CANNABIS AND YOUR HEALTH
Underpinned by his two-year research trial in partnership with the Royal College of Psychiatrists, involving up to 20,000 patients, which will create Europe's largest body of evidence on the plant's medicinal qualities - Professor David Nutt and his team of scientists will break the mould on the way we use Cannabis for our health in the future.
In David's first ground-breaking book on the subject, he will cover its impact of all areas of the body and the brain and its effective use for treatment of illness from chronic pain, epilepsy, multiple sclerosis and PTSD, to anxiety and depression. This is the essential knowledge that cuts through the noise and give us evidence-based information that will change people's lives.
David Nutt is Professor of Neuropsychopharmacology and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences at Imperial College, London.After completing his medical training at Guy's Hospital London, continuing in neurology to MRCP, he went on to his psychiatric training in Oxford, he continued there as a lecturer and then later as a Wellcome Senior Fellow in psychiatry. He then spent two years as Chief of the Section of Clinical Science in the National Institute of Alcohol Abuse and Alcoholism in NIH, Bethesda, USA. On returning to England in 1988 he set up the Psychopharmacology Unit in Bristol University, an interdisciplinary research grouping spanning the departments of Psychiatry and Pharmacology before moving to Imperial College London in December 2008 where he leads a similar group with a particular focus on brain imaging especially PET.David is currently Chair of DrugScience (formally the Independent Scientific Committee on Drugs (ISCD) and President of the European Brain Council. previously he has been President of the European College of Neuropsychopharmacology (ECNP), the British Neuroscience Association (BNA) and the British Association of Psychopharmacology (BAP). In addition, he is a Fellow of the Royal Colleges of Physicians and of Psychiatrists and a Fellow of the Academy of Medical Sciences. He is also the UK Director of the European Certificate and Masters in Affective Disorders Courses and a member of the International Centre for Science in Drug Policy. He has edited the Journal of Psychopharmacology for over two decades and acts as the psychiatry drugs advisor to the British National Formulary.Previously he has been a member and then Chair of the Advisory Committee on the Misuse of Drugs (ACMD - 1998-2009), a member of the HEFCE/NHS Senior Lecturer Selection Panel and of the MRC Neuroscience Board. Other previous national contributions include serving as the medical expert on the Independent Inquiry into the Misuse of Drugs Act (2000 Runciman report), and membership of the Committee on Safety of Medicines, the Committee on NHS drugs and the Ministry of Defence Science Advisory Board. He was the clinical scientific lead on the 2004/5 UK Government Foresight initiative Brain science, addiction and drugs that provided a 25-year vision for this area of science and public policy.David broadcasts widely to the general public both on radio and television including BBC science and public affairs programmes on therapeutic as well as illicit drugs, their harms and their classification. He also lecturers widely to the public as well as to the scientific and medical communities; he has presented three time at the Cheltenham Science Festival and several times for Café Scientifiques.
